Print

RV 156

A Phase I Clinical Trial to Evaluate the Safety and Immunogenicity of a Multiclade HIV-1 DNA Plasmid Vaccine, VRC-HIVDN A009-00-VP, in Uninfected Adult Volunteers in Uganda

Trial Details:

I Completed
National Institute of Allergy and Infectious Diseases (NIAID), HIV Vaccine Trials Network (HVTN), Vaccine Research Center (VRC), U.S. Military HIV Research Program (MHRP), Makerere University January 10, 2005
VRC-HIVDNA009-00-VP gagB, pol B, nef B, env A, env, B, env C
VRC-HIVDNA009-00-VP DNA
Uganda 31